doi: 10.1038/oby.2007.53
They are often discussed together, prescribed for similar conditions, and confused for one another yet they are meaningfully different drugs with distinct mechanisms, efficacy profiles, approval statuses, and ideal candidates
It simultaneously targets GLP-1, GIP, and glucagon receptors, showing superior results in preclinical studies for weight management, energy expenditure, body composition, hepatic lipid metabolism, NASH/NAFLD, thermogenesis, and long-term metabolic homeostasis
Age-related macular degeneration (AMD) Dry AMD (geographic atrophy): Progressive RPE and photoreceptor loss in macula causing central vision decline
PlexusDx doesn't require insurance, but HSA and FSA accounts are accepted